Section 4-41a-802 - Report(1) At or before the November interim meeting each year, the department shall report to the Health and Human Services Interim Committee on:(a) the number of applications and renewal applications that the department receives under this chapter;(b) the number of each type of cannabis production facility that the department licenses in each county;(c) the amount of cannabis that licensees grow;(d) the amount of cannabis that licensees manufacture into cannabis products;(e) the number of licenses the department revokes under this chapter;(f) the department's operation of an independent cannabis testing laboratory under Section 4-41a-201, including: (i) the cannabis and cannabis products the department tested; and(ii) the results of the tests the department performed;(g) the expenses incurred and revenues generated under this chapter; and(h) an analysis of product availability in medical cannabis pharmacies in consultation with the Department of Health and Human Services.(2) The department may not include personally identifying information in the report described in this section.(3) The department shall report to the working group described in Section 36-12-8.2 as requested by the working group.Amended by Chapter 217, 2024 General Session ,§ 9, eff. 5/1/2024.Amended by Chapter 273, 2023 General Session ,§ 10, eff. 5/3/2023.Amended by Chapter 97, 2022 General Session ,§ 1, eff. 3/21/2022.Amended by Chapter 148, 2020 General Session ,§ 5, eff. 3/24/2020.Renumbered from §4-41b-802 and amended by Chapter 1, 2018SP3 General Session ,§ 29, eff. 12/3/2018.Added by Utah Proposition 2, Medical Marijuana Initiative (2018), approved by the voters at the general election held on 11/6/2018, and effective 12/1/2018.